<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://jop.sagepub.com/">
<title>J Psychopharmacol: Most-Read Full-Text Articles</title>
<link>http://jop.sagepub.com/</link>
<description>Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month.</description>
<prism:coverDisplayDate>2009-11-09</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/1/3?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/4/346?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/22/4/343?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/1/65?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/5/574?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/19/6/567?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/5/495?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/21/8/864?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/21/8/792?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/21/8/787?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/22/8/821?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/6/714?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/21/4/440?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/7/831?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/7/733?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/4/389?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/19/2/187?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/22/6/603?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/0269881109106900v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/19/1/59?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/13/2/180?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/7/745?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/4/392?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/5/510?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/7/841?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/18/3/293?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/17/2/149?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/20/6/732?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/15/2/127?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/2/194?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/22/3/308?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/5/475?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/21/8/815?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/20/2_suppl/46?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/3/241?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/6/605?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/19/4/414?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/6/708?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/7/814?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/20/1/14?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/1/14?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/21/5/538?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/22/6/621?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/7/759?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/0269881109106910v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/20/4/580?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/23/7/789?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/20/6_suppl/6?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/22/7/727?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://jop.sagepub.com/cgi/content/short/18/2/262?rss=1&amp;ssource=mfc" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/1/3?rss=1&amp;ssource=mfc">
<title><![CDATA[Equasy -- An overlooked addiction with implications for the current debate on drug harms]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/1/3?rss=1&amp;ssource=mfc</link>
<description><![CDATA[DJ Nutt<br />Jan  1, 2009; 23:3-5<br />Article]]></description>
<dc:creator>DJ Nutt</dc:creator>
<dc:date>2009-01-01</dc:date>
<dc:identifier>10.1177/0269881108099672</dc:identifier>
<dc:title><![CDATA[Equasy -- An overlooked addiction with implications for the current debate on drug harms]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/4/346?rss=1&amp;ssource=mfc">
<title><![CDATA[Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/4/346?rss=1&amp;ssource=mfc</link>
<description><![CDATA[GM Goodwin,   Consensus Group of the British Association for Psychopharmacology<br />Jun  1, 2009; 23:346-388<br />Article]]></description>
<dc:creator>GM Goodwin,   Consensus Group of the British Association for Psychopharmacology</dc:creator>
<dc:date>2009-06-01</dc:date>
<dc:title><![CDATA[Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/22/4/343?rss=1&amp;ssource=mfc">
<title><![CDATA[Evidence-based guidelines for treating depressive disorders with         antidepressants: A revision of the 2000 British Association for Psychopharmacology         guidelines]]></title>
<link>http://jop.sagepub.com/cgi/content/short/22/4/343?rss=1&amp;ssource=mfc</link>
<description><![CDATA[IM Anderson, IN Ferrier, RC Baldwin, PJ Cowen, L Howard, G Lewis, K Matthews, RH McAllister-Williams, RC Peveler, J Scott, A Tylee<br />Jun  1, 2008; 22:343-396<br />Article]]></description>
<dc:creator>IM Anderson, IN Ferrier, RC Baldwin, PJ Cowen, L Howard, G Lewis, K Matthews, RH McAllister-Williams, RC Peveler, J Scott, A Tylee</dc:creator>
<dc:date>2008-06-01</dc:date>
<dc:title><![CDATA[Evidence-based guidelines for treating depressive disorders with         antidepressants: A revision of the 2000 British Association for Psychopharmacology         guidelines]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/1/65?rss=1&amp;ssource=mfc">
<title><![CDATA[Asenapine: a novel psychopharmacologic agent with a unique human receptor signature]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/1/65?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M. Shahid, GB Walker, SH Zorn, Ehf Wong<br />Jan  1, 2009; 23:65-73<br />Article]]></description>
<dc:creator>M. Shahid, GB Walker, SH Zorn, Ehf Wong</dc:creator>
<dc:date>2009-01-01</dc:date>
<dc:title><![CDATA[Asenapine: a novel psychopharmacologic agent with a unique human receptor signature]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/5/574?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/5/574?rss=1&amp;ssource=mfc</link>
<description><![CDATA[S Beynon, K Soares-Weiser, N Woolacott, S Duffy, JR Geddes<br />Jul  1, 2009; 23:574-591<br />Article]]></description>
<dc:creator>S Beynon, K Soares-Weiser, N Woolacott, S Duffy, JR Geddes</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/19/6/567?rss=1&amp;ssource=mfc">
<title><![CDATA[Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology]]></title>
<link>http://jop.sagepub.com/cgi/content/short/19/6/567?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David S. Baldwin, Ian M. Anderson, David J. Nutt, Borwin Bandelow, A. Bond, Jonathan R. T. Davidson, J. A. den Boer, Naomi A. Fineberg, Martin Knapp, J. Scott, H. -U. Wittchen<br />Nov  1, 2005; 19:567-596<br />Article]]></description>
<dc:creator>David S. Baldwin, Ian M. Anderson, David J. Nutt, Borwin Bandelow, A. Bond, Jonathan R. T. Davidson, J. A. den Boer, Naomi A. Fineberg, Martin Knapp, J. Scott, H. -U. Wittchen</dc:creator>
<dc:date>2005-11-01</dc:date>
<dc:identifier>10.1177/0269881105059253</dc:identifier>
<dc:title><![CDATA[Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/5/495?rss=1&amp;ssource=mfc">
<title><![CDATA[Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/5/495?rss=1&amp;ssource=mfc</link>
<description><![CDATA[F Indlekofer, M Piechatzek, M Daamen, C Glasmacher, R Lieb, H Pfister, O Tucha, KW Lange, HU Wittchen, CG Schutz<br />Jul  1, 2009; 23:495-509<br />Article]]></description>
<dc:creator>F Indlekofer, M Piechatzek, M Daamen, C Glasmacher, R Lieb, H Pfister, O Tucha, KW Lange, HU Wittchen, CG Schutz</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/21/8/864?rss=1&amp;ssource=mfc">
<title><![CDATA[An effect-size analysis of pharmacologic treatments for generalized anxiety disorder]]></title>
<link>http://jop.sagepub.com/cgi/content/short/21/8/864?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Rosario B. Hidalgo, Larry A. Tupler, Jonathan R. T. Davidson<br />Nov  1, 2007; 21:864-872<br />Article]]></description>
<dc:creator>Rosario B. Hidalgo, Larry A. Tupler, Jonathan R. T. Davidson</dc:creator>
<dc:date>2007-11-01</dc:date>
<dc:identifier>10.1177/0269881107076996</dc:identifier>
<dc:title><![CDATA[An effect-size analysis of pharmacologic treatments for generalized anxiety disorder]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/21/8/792?rss=1&amp;ssource=mfc">
<title><![CDATA[Substance use and the adolescent brain: A toxic combination?]]></title>
<link>http://jop.sagepub.com/cgi/content/short/21/8/792?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Dan I. Lubman, Murat Yucel, Wayne D. Hall<br />Nov  1, 2007; 21:792-794<br />Article]]></description>
<dc:creator>Dan I. Lubman, Murat Yucel, Wayne D. Hall</dc:creator>
<dc:date>2007-11-01</dc:date>
<dc:identifier>10.1177/0269881107078309</dc:identifier>
<dc:title><![CDATA[Substance use and the adolescent brain: A toxic combination?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/21/8/787?rss=1&amp;ssource=mfc">
<title><![CDATA[MDMA, politics and medical research: Have we thrown the baby out with the bathwater?]]></title>
<link>http://jop.sagepub.com/cgi/content/short/21/8/787?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ben Sessa, David J. Nutt<br />Nov  1, 2007; 21:787-791<br />Article]]></description>
<dc:creator>Ben Sessa, David J. Nutt</dc:creator>
<dc:date>2007-11-01</dc:date>
<dc:identifier>10.1177/0269881107084738</dc:identifier>
<dc:title><![CDATA[MDMA, politics and medical research: Have we thrown the baby out with the bathwater?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/22/8/821?rss=1&amp;ssource=mfc">
<title><![CDATA[Is it time to revisit the role of psychedelic drugs in enhancing human creativity?]]></title>
<link>http://jop.sagepub.com/cgi/content/short/22/8/821?rss=1&amp;ssource=mfc</link>
<description><![CDATA[B. Sessa<br />Nov  1, 2008; 22:821-827<br />Article]]></description>
<dc:creator>B. Sessa</dc:creator>
<dc:date>2008-11-01</dc:date>
<dc:title><![CDATA[Is it time to revisit the role of psychedelic drugs in enhancing human creativity?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/6/714?rss=1&amp;ssource=mfc">
<title><![CDATA[Long-term effects of cannabis on oculomotor function in humans]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/6/714?rss=1&amp;ssource=mfc</link>
<description><![CDATA[L Huestegge, R Radach, HJ Kunert<br />Aug  1, 2009; 23:714-722<br />Short report]]></description>
<dc:creator>L Huestegge, R Radach, HJ Kunert</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Long-term effects of cannabis on oculomotor function in humans]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/21/4/440?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Glutamate and dopamine dysregulation in schizophrenia   a         synthesis and selective review]]></title>
<link>http://jop.sagepub.com/cgi/content/short/21/4/440?rss=1&amp;ssource=mfc</link>
<description><![CDATA[James M. Stone, Paul D. Morrison, Lyn S. Pilowsky<br />Jun  1, 2007; 21:440-452<br />Article]]></description>
<dc:creator>James M. Stone, Paul D. Morrison, Lyn S. Pilowsky</dc:creator>
<dc:date>2007-06-01</dc:date>
<dc:title><![CDATA[Review: Glutamate and dopamine dysregulation in schizophrenia   a         synthesis and selective review]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/7/831?rss=1&amp;ssource=mfc">
<title><![CDATA[Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/7/831?rss=1&amp;ssource=mfc</link>
<description><![CDATA[N Antypa, AJW Van der Does, AHM Smelt, RD Rogers<br />Sep  1, 2009; 23:831-840<br />Article]]></description>
<dc:creator>N Antypa, AJW Van der Does, AHM Smelt, RD Rogers</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/7/733?rss=1&amp;ssource=mfc">
<title><![CDATA[Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/7/733?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M Koesters, T Becker, R Kilian, JM Fegert, S Weinmann<br />Sep  1, 2009; 23:733-744<br />Article]]></description>
<dc:creator>M Koesters, T Becker, R Kilian, JM Fegert, S Weinmann</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/4/389?rss=1&amp;ssource=mfc">
<title><![CDATA[How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/4/389?rss=1&amp;ssource=mfc</link>
<description><![CDATA[PO Johansen, TS Krebs<br />Jun  1, 2009; 23:389-391<br />Article]]></description>
<dc:creator>PO Johansen, TS Krebs</dc:creator>
<dc:date>2009-06-01</dc:date>
<dc:title><![CDATA[How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/19/2/187?rss=1&amp;ssource=mfc">
<title><![CDATA[Cannabis as a risk factor for psychosis: systematic review]]></title>
<link>http://jop.sagepub.com/cgi/content/short/19/2/187?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David M. Semple, Andrew M. McIntosh, Stephen M. Lawrie<br />Mar  1, 2005; 19:187-194<br />Article]]></description>
<dc:creator>David M. Semple, Andrew M. McIntosh, Stephen M. Lawrie</dc:creator>
<dc:date>2005-03-01</dc:date>
<dc:identifier>10.1177/0269881105049040</dc:identifier>
<dc:title><![CDATA[Cannabis as a risk factor for psychosis: systematic review]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/22/6/603?rss=1&amp;ssource=mfc">
<title><![CDATA[Human hallucinogen research: guidelines for safety]]></title>
<link>http://jop.sagepub.com/cgi/content/short/22/6/603?rss=1&amp;ssource=mfc</link>
<description><![CDATA[MW Johnson, WA Richards, RR Griffiths<br />Aug  1, 2008; 22:603-620<br />Article]]></description>
<dc:creator>MW Johnson, WA Richards, RR Griffiths</dc:creator>
<dc:date>2008-08-01</dc:date>
<dc:title><![CDATA[Human hallucinogen research: guidelines for safety]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/0269881109106900v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Olanzapine in the long-term treatment of bipolar disorder: A systematic review and meta-analysis]]></title>
<link>http://jop.sagepub.com/cgi/content/short/0269881109106900v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Andrea Cipriani, Jennifer Rendell, John R Geddes<br />Oct 14, 2009; 0:26988110<br />Article]]></description>
<dc:creator>Andrea Cipriani, Jennifer Rendell, John R Geddes</dc:creator>
<dc:date>2009-10-14</dc:date>
<dc:title><![CDATA[Olanzapine in the long-term treatment of bipolar disorder: A systematic review and meta-analysis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/19/1/59?rss=1&amp;ssource=mfc">
<title><![CDATA[Treatment of depression: time to consider folic acid and vitamin B12]]></title>
<link>http://jop.sagepub.com/cgi/content/short/19/1/59?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Alec Coppen, Christina Bolander-Gouaille<br />Jan  1, 2005; 19:59-65<br />Article]]></description>
<dc:creator>Alec Coppen, Christina Bolander-Gouaille</dc:creator>
<dc:date>2005-01-01</dc:date>
<dc:identifier>10.1177/0269881105048899</dc:identifier>
<dc:title><![CDATA[Treatment of depression: time to consider folic acid and vitamin B12]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/13/2/180?rss=1&amp;ssource=mfc">
<title><![CDATA[Impulsivity: a discussion of clinical and experimental findings]]></title>
<link>http://jop.sagepub.com/cgi/content/short/13/2/180?rss=1&amp;ssource=mfc</link>
<description><![CDATA[John Evenden<br />Mar  1, 1999; 13:180-192<br />Article]]></description>
<dc:creator>John Evenden</dc:creator>
<dc:date>1999-03-01</dc:date>
<dc:identifier>10.1177/026988119901300211</dc:identifier>
<dc:title><![CDATA[Impulsivity: a discussion of clinical and experimental findings]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/7/745?rss=1&amp;ssource=mfc">
<title><![CDATA[Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/7/745?rss=1&amp;ssource=mfc</link>
<description><![CDATA[K Soar, A Parrott, J Turner<br />Sep  1, 2009; 23:745-758<br />Article]]></description>
<dc:creator>K Soar, A Parrott, J Turner</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/4/392?rss=1&amp;ssource=mfc">
<title><![CDATA[That warm fuzzy feeling: brain serotonergic neurons and the regulation of emotion]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/4/392?rss=1&amp;ssource=mfc</link>
<description><![CDATA[CA Lowry, SL Lightman, DJ Nutt<br />Jun  1, 2009; 23:392-400<br />Article]]></description>
<dc:creator>CA Lowry, SL Lightman, DJ Nutt</dc:creator>
<dc:date>2009-06-01</dc:date>
<dc:title><![CDATA[That warm fuzzy feeling: brain serotonergic neurons and the regulation of emotion]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/5/510?rss=1&amp;ssource=mfc">
<title><![CDATA[The addiction Stroop task: examining the fast and slow effects of smoking and marijuana-related cues]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/5/510?rss=1&amp;ssource=mfc</link>
<description><![CDATA[JE Cane, D Sharma, IP Albery<br />Jul  1, 2009; 23:510-519<br />Article]]></description>
<dc:creator>JE Cane, D Sharma, IP Albery</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[The addiction Stroop task: examining the fast and slow effects of smoking and marijuana-related cues]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/7/841?rss=1&amp;ssource=mfc">
<title><![CDATA[Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/7/841?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M Ebinger, C Sievers, D Ivan, HJ Schneider, GK Stalla<br />Sep  1, 2009; 23:841-853<br />Article]]></description>
<dc:creator>M Ebinger, C Sievers, D Ivan, HJ Schneider, GK Stalla</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/18/3/293?rss=1&amp;ssource=mfc">
<title><![CDATA[Evidence-Based Guidelines for the Pharmacological Management of Substance         Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology]]></title>
<link>http://jop.sagepub.com/cgi/content/short/18/3/293?rss=1&amp;ssource=mfc</link>
<description><![CDATA[A. R. Lingford-Hughes, S. Welch, D. J. Nutt<br />Sep  1, 2004; 18:293-335<br />Article]]></description>
<dc:creator>A. R. Lingford-Hughes, S. Welch, D. J. Nutt</dc:creator>
<dc:date>2004-09-01</dc:date>
<dc:identifier>10.1177/026988110401800321</dc:identifier>
<dc:title><![CDATA[Evidence-Based Guidelines for the Pharmacological Management of Substance         Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/17/2/149?rss=1&amp;ssource=mfc">
<title><![CDATA[Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from        the British Association for Psychopharmacology]]></title>
<link>http://jop.sagepub.com/cgi/content/short/17/2/149?rss=1&amp;ssource=mfc</link>
<description><![CDATA[G. M. Goodwin<br />Jun  1, 2003; 17:149-173<br />Article]]></description>
<dc:creator>G. M. Goodwin</dc:creator>
<dc:date>2003-06-01</dc:date>
<dc:identifier>10.1177/0269881103017002003</dc:identifier>
<dc:title><![CDATA[Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from        the British Association for Psychopharmacology]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/20/6/732?rss=1&amp;ssource=mfc">
<title><![CDATA[Clinical practice with anti-dementia drugs: a consensus statement from         British Association for Psychopharmacology]]></title>
<link>http://jop.sagepub.com/cgi/content/short/20/6/732?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Alistair Burns, John O''Brien<br />Nov  1, 2006; 20:732-755<br />Article]]></description>
<dc:creator>Alistair Burns, John O''Brien</dc:creator>
<dc:date>2006-11-01</dc:date>
<dc:identifier>10.1177/0269881106068299</dc:identifier>
<dc:title><![CDATA[Clinical practice with anti-dementia drugs: a consensus statement from         British Association for Psychopharmacology]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/15/2/127?rss=1&amp;ssource=mfc">
<title><![CDATA[Suicide and schizophrenia]]></title>
<link>http://jop.sagepub.com/cgi/content/short/15/2/127?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Samuel G. Siris<br />Mar  1, 2001; 15:127-135<br />Article]]></description>
<dc:creator>Samuel G. Siris</dc:creator>
<dc:date>2001-03-01</dc:date>
<dc:identifier>10.1177/026988110101500209</dc:identifier>
<dc:title><![CDATA[Suicide and schizophrenia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/2/194?rss=1&amp;ssource=mfc">
<title><![CDATA[Safety of therapeutic methylphenidate in adults: a systematic review of the evidence]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/2/194?rss=1&amp;ssource=mfc</link>
<description><![CDATA[J Godfrey<br />Mar  1, 2009; 23:194-205<br />Article]]></description>
<dc:creator>J Godfrey</dc:creator>
<dc:date>2009-03-01</dc:date>
<dc:title><![CDATA[Safety of therapeutic methylphenidate in adults: a systematic review of the evidence]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/22/3/308?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia]]></title>
<link>http://jop.sagepub.com/cgi/content/short/22/3/308?rss=1&amp;ssource=mfc</link>
<description><![CDATA[PJ Harrison, L. Lyon, LJ Sartorius, Pwj Burnet, TA Lane<br />May  1, 2008; 22:308-322<br />Article]]></description>
<dc:creator>PJ Harrison, L. Lyon, LJ Sartorius, Pwj Burnet, TA Lane</dc:creator>
<dc:date>2008-05-01</dc:date>
<dc:identifier>10.1177/0269881108089818</dc:identifier>
<dc:title><![CDATA[Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/5/475?rss=1&amp;ssource=mfc">
<title><![CDATA[Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/5/475?rss=1&amp;ssource=mfc</link>
<description><![CDATA[LM Paterson, SJ Wilson, DJ Nutt, PH Hutson, M Ivarsson<br />Jul  1, 2009; 23:475-486<br />Article]]></description>
<dc:creator>LM Paterson, SJ Wilson, DJ Nutt, PH Hutson, M Ivarsson</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/21/8/815?rss=1&amp;ssource=mfc">
<title><![CDATA[Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists]]></title>
<link>http://jop.sagepub.com/cgi/content/short/21/8/815?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Laraine James, Thomas R.E. Barnes, Paul Lelliott, David Taylor, Carol Paton<br />Nov  1, 2007; 21:815-819<br />Article]]></description>
<dc:creator>Laraine James, Thomas R.E. Barnes, Paul Lelliott, David Taylor, Carol Paton</dc:creator>
<dc:date>2007-11-01</dc:date>
<dc:title><![CDATA[Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/20/2_suppl/46?rss=1&amp;ssource=mfc">
<title><![CDATA[Psychotherapy for bipolar disorders - efficacy and effectiveness]]></title>
<link>http://jop.sagepub.com/cgi/content/short/20/2_suppl/46?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jan Scott<br />Mar  1, 2006; 20:46-50<br />Article]]></description>
<dc:creator>Jan Scott</dc:creator>
<dc:date>2006-03-01</dc:date>
<dc:identifier>10.1177/1359786806063078</dc:identifier>
<dc:title><![CDATA[Psychotherapy for bipolar disorders - efficacy and effectiveness]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/3/241?rss=1&amp;ssource=mfc">
<title><![CDATA[Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/3/241?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M Di Simplicio, R Massey-Chase, PJ Cowen, CJ Harmer<br />May  1, 2009; 23:241-248<br />Article]]></description>
<dc:creator>M Di Simplicio, R Massey-Chase, PJ Cowen, CJ Harmer</dc:creator>
<dc:date>2009-05-01</dc:date>
<dc:title><![CDATA[Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/6/605?rss=1&amp;ssource=mfc">
<title><![CDATA[STAR*D: a summary and UK perspective]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/6/605?rss=1&amp;ssource=mfc</link>
<description><![CDATA[J Deakin, C O''Loughlin<br />Aug  1, 2009; 23:605-612<br />Critique]]></description>
<dc:creator>J Deakin, C O''Loughlin</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[STAR*D: a summary and UK perspective]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/19/4/414?rss=1&amp;ssource=mfc">
<title><![CDATA[Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability]]></title>
<link>http://jop.sagepub.com/cgi/content/short/19/4/414?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David Wheatley<br />Jul  1, 2005; 19:414-421<br />Article]]></description>
<dc:creator>David Wheatley</dc:creator>
<dc:date>2005-07-01</dc:date>
<dc:identifier>10.1177/0269881105053309</dc:identifier>
<dc:title><![CDATA[Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/6/708?rss=1&amp;ssource=mfc">
<title><![CDATA[Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/6/708?rss=1&amp;ssource=mfc</link>
<description><![CDATA[WW van den Broek, PGH Mulder, E van Os, TK Birkenhager, E Pluijms, JA Bruijn<br />Aug  1, 2009; 23:708-713<br />Review]]></description>
<dc:creator>WW van den Broek, PGH Mulder, E van Os, TK Birkenhager, E Pluijms, JA Bruijn</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/7/814?rss=1&amp;ssource=mfc">
<title><![CDATA[Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/7/814?rss=1&amp;ssource=mfc</link>
<description><![CDATA[CK Martin, H Han, SD Anton, FL Greenway, SR Smith<br />Sep  1, 2009; 23:814-825<br />Article]]></description>
<dc:creator>CK Martin, H Han, SD Anton, FL Greenway, SR Smith</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/20/1/14?rss=1&amp;ssource=mfc">
<title><![CDATA[Cannabis use, cognitive performance and mood in a sample of workers]]></title>
<link>http://jop.sagepub.com/cgi/content/short/20/1/14?rss=1&amp;ssource=mfc</link>
<description><![CDATA[E. J. K. Wadsworth, S. C. Moss, S. A. Simpson, A. P. Smith<br />Jan  1, 2006; 20:14-23<br />Article]]></description>
<dc:creator>E. J. K. Wadsworth, S. C. Moss, S. A. Simpson, A. P. Smith</dc:creator>
<dc:date>2006-01-01</dc:date>
<dc:title><![CDATA[Cannabis use, cognitive performance and mood in a sample of workers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/1/14?rss=1&amp;ssource=mfc">
<title><![CDATA[Disrupted `reflection' impulsivity in cannabis users but not current or former ecstasy users]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/1/14?rss=1&amp;ssource=mfc</link>
<description><![CDATA[L. Clark, JP Roiser, TW Robbins, BJ Sahakian<br />Jan  1, 2009; 23:14-22<br />Article]]></description>
<dc:creator>L. Clark, JP Roiser, TW Robbins, BJ Sahakian</dc:creator>
<dc:date>2009-01-01</dc:date>
<dc:title><![CDATA[Disrupted `reflection' impulsivity in cannabis users but not current or former ecstasy users]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/21/5/538?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Serotonin by stress interaction: a susceptibility factor for the         development of depression?]]></title>
<link>http://jop.sagepub.com/cgi/content/short/21/5/538?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Christine Firk, C. Rob Markus<br />Jul  1, 2007; 21:538-544<br />Article]]></description>
<dc:creator>Christine Firk, C. Rob Markus</dc:creator>
<dc:date>2007-07-01</dc:date>
<dc:title><![CDATA[Review: Serotonin by stress interaction: a susceptibility factor for the         development of depression?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/22/6/621?rss=1&amp;ssource=mfc">
<title><![CDATA[Mystical-type experiences occasioned by psilocybin mediate the attribution of         personal meaning and spiritual significance 14 months later]]></title>
<link>http://jop.sagepub.com/cgi/content/short/22/6/621?rss=1&amp;ssource=mfc</link>
<description><![CDATA[RR Griffiths, WA Richards, MW Johnson, UD McCann, R. Jesse<br />Aug  1, 2008; 22:621-632<br />Article]]></description>
<dc:creator>RR Griffiths, WA Richards, MW Johnson, UD McCann, R. Jesse</dc:creator>
<dc:date>2008-08-01</dc:date>
<dc:title><![CDATA[Mystical-type experiences occasioned by psilocybin mediate the attribution of         personal meaning and spiritual significance 14 months later]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/7/759?rss=1&amp;ssource=mfc">
<title><![CDATA[Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/7/759?rss=1&amp;ssource=mfc</link>
<description><![CDATA[K Allott, BJ Canny, JH Broadbear, NK Stepto, B Murphy, J Redman<br />Sep  1, 2009; 23:759-774<br />Article]]></description>
<dc:creator>K Allott, BJ Canny, JH Broadbear, NK Stepto, B Murphy, J Redman</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/0269881109106910v1?rss=1&amp;ssource=mfc">
<title><![CDATA[The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines]]></title>
<link>http://jop.sagepub.com/cgi/content/short/0269881109106910v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Maria S Garcia-Gutierrez, Jorge Manzanares<br />Oct 13, 2009; 0:26988110<br />Article]]></description>
<dc:creator>Maria S Garcia-Gutierrez, Jorge Manzanares</dc:creator>
<dc:date>2009-10-13</dc:date>
<dc:title><![CDATA[The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/20/4/580?rss=1&amp;ssource=mfc">
<title><![CDATA[Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for         the study of addictions in youth]]></title>
<link>http://jop.sagepub.com/cgi/content/short/20/4/580?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Timothy E. Wilens, Joseph Biederman<br />Jul  1, 2006; 20:580-588<br />Article]]></description>
<dc:creator>Timothy E. Wilens, Joseph Biederman</dc:creator>
<dc:date>2006-07-01</dc:date>
<dc:title><![CDATA[Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for         the study of addictions in youth]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/23/7/789?rss=1&amp;ssource=mfc">
<title><![CDATA[Depot and oral antipsychotics: patient preferences and attitudes are not the same thing]]></title>
<link>http://jop.sagepub.com/cgi/content/short/23/7/789?rss=1&amp;ssource=mfc</link>
<description><![CDATA[MX Patel, N De Zoysa, M Bernadt, A David<br />Sep  1, 2009; 23:789-796<br />Article]]></description>
<dc:creator>MX Patel, N De Zoysa, M Bernadt, A David</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Depot and oral antipsychotics: patient preferences and attitudes are not the same thing]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/20/6_suppl/6?rss=1&amp;ssource=mfc">
<title><![CDATA[Symptom domains of schizophrenia: the role of atypical antipsychotic agents]]></title>
<link>http://jop.sagepub.com/cgi/content/short/20/6_suppl/6?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Simon Burton<br />Nov  1, 2006; 20:6-19<br />Article]]></description>
<dc:creator>Simon Burton</dc:creator>
<dc:date>2006-11-01</dc:date>
<dc:identifier>10.1177/1359786806071237</dc:identifier>
<dc:title><![CDATA[Symptom domains of schizophrenia: the role of atypical antipsychotic agents]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/22/7/727?rss=1&amp;ssource=mfc">
<title><![CDATA[Real-world memory and executive processes in cannabis users and non-users]]></title>
<link>http://jop.sagepub.com/cgi/content/short/22/7/727?rss=1&amp;ssource=mfc</link>
<description><![CDATA[JE Fisk, C. Montgomery<br />Sep  1, 2008; 22:727-736<br />Article]]></description>
<dc:creator>JE Fisk, C. Montgomery</dc:creator>
<dc:date>2008-09-01</dc:date>
<dc:title><![CDATA[Real-world memory and executive processes in cannabis users and non-users]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://jop.sagepub.com/cgi/content/short/18/2/262?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetic Interactions of Drugs with St John's Wort]]></title>
<link>http://jop.sagepub.com/cgi/content/short/18/2/262?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Shufeng Zhou, Eli Chan, Shen-Quan Pan, Min Huang, Edmund Jon Deoon Lee<br />Jun  1, 2004; 18:262-276<br />Article]]></description>
<dc:creator>Shufeng Zhou, Eli Chan, Shen-Quan Pan, Min Huang, Edmund Jon Deoon Lee</dc:creator>
<dc:date>2004-06-01</dc:date>
<dc:identifier>10.1177/0269881104042632</dc:identifier>
<dc:title><![CDATA[Pharmacokinetic Interactions of Drugs with St John's Wort]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

</rdf:RDF>